Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5676
The 3D Printing ETF
PRNT
$61.5M
| $270K | ﹤0.01% |
11,002
-1,165
| -10% | -$27.6K |
2017 Q1
37 quarters
|
|
5677
Humacyte
HUMA
$98.4M
| $269K | ﹤0.01% |
345,122
+158,379
| +85% | +$147K |
2021 Q1
21 quarters
|
|
5678
Alger Concentrated Equity ETF
CNEQ
$3.27B
| $268K | ﹤0.01% |
6,504
+5,484
| +538% | +$209K |
2026 Q1
1 quarter
|
|
|
ACMG
5679
American Century Mid Cap Growth Insights ETF
ACMG
$104M
| $267K | ﹤0.01% |
3,886
+2,405
| +162% | +$158K |
2024 Q4
6 quarters
|
|
|
DHY
5680
UBS Asset Management High Yield Credit Fund
DHY
$223M
| $266K | ﹤0.01% |
14,965
-26,946
| -64% | -$480K |
2013 Q2
52 quarters
|
|
5681
Kodiak AI
KDK
$313M
| $266K | ﹤0.01% |
52,267
-51,661
| -50% | -$387K |
2025 Q3
3 quarters
|
|
5682
Xtrackers Artificial Intelligence and Big Data ETF
XAIX
$159M
| $265K | ﹤0.01% |
4,608
+970
| +27% | +$50K |
2025 Q2
4 quarters
|
|
5683
Byrna Technologies
BYRN
$109M
| $265K | ﹤0.01% |
39,484
-13,712
| -26% | -$84.2K |
2021 Q2
20 quarters
|
|
5684
Larimar Therapeutics
LRMR
$217M
| $265K | ﹤0.01% |
86,858
-333,955
| -79% | -$1.33M |
2014 Q3
47 quarters
|
|
5685
Prairie Operating Co
PROP
$41.5M
| $264K | ﹤0.01% |
366,506
-86,355
| -19% | -$93K |
2023 Q4
10 quarters
|
|
5686
Hartford Alpha Capture Value ETF
ACVU
$274M
| $264K | ﹤0.01% |
8,460
+221
| +3% | +$6.56K |
2023 Q4
10 quarters
|
|
5687
Curis
CRIS
$1.45M
| $263K | ﹤0.01% |
25,215
+12,503
| +98% | +$128K |
2013 Q2
52 quarters
|
|
5688
International Tower Hill Mines
THM
$523M
| $263K | ﹤0.01% |
132,210
+15,624
| +13% | +$37.4K |
2017 Q3
35 quarters
|
|
5689
Direxion Daily FTSE China Bull 3X ETF
YINN
$580M
| $263K | ﹤0.01% |
12,241
+1,500
| +14% | +$47.5K |
2018 Q4
30 quarters
|
|
5690
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.29B
| $263K | ﹤0.01% |
5,498
-1,335
| -20% | -$63.9K |
2024 Q4
6 quarters
|
|
5691
Benitec Biopharma
BNTC
$289M
| $262K | ﹤0.01% |
19,576
-9,694
| -33% | -$115K |
2023 Q4
10 quarters
|
|
5692
Franklin FTSE Japan Hedged ETF
FLJH
$206M
| $262K | ﹤0.01% |
5,735
| – | – |
2023 Q2
12 quarters
|
|
5693
Universal Logistics Holdings
ULH
$444M
| $262K | ﹤0.01% |
17,675
-16,285
| -48% | -$291K |
2013 Q2
52 quarters
|
|
5694
Montauk Renewables
MNTK
$309M
| $261K | ﹤0.01% |
167,182
-94,216
| -36% | -$139K |
2021 Q1
21 quarters
|
|
5695
Teucrium Wheat Fund
WEAT
$274M
| $260K | ﹤0.01% |
11,824
-302
| -2% | -$7.02K |
2017 Q4
34 quarters
|
|
5696
ProShares UltraPro Short S&P 500
SPXU
$417M
| $258K | ﹤0.01% |
6,951
+4,943
| +246% | +$205K |
2013 Q3
51 quarters
|
|
5697
First Northern Community Bancorp
FNRN
$273M
| $258K | ﹤0.01% |
+14,363
| New | +$250K |
2026 Q2
0 quarters
|
|
5698
Calvert US Large-Cap Core Responsible Index ETF
CVLC
$996M
| $257K | ﹤0.01% |
2,716
| – | – |
2023 Q1
13 quarters
|
|
5699
Cellectis
CLLS
$113M
| $256K | ﹤0.01% |
85,455
-1,321
| -2% | -$4.7K |
2015 Q1
45 quarters
|
|
5700
Goldman Sachs ActiveBeta Europe Equity ETF
GSEU
$170M
| $256K | ﹤0.01% |
5,266
-420
| -7% | -$20.2K |
2016 Q2
40 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.